213 related articles for article (PubMed ID: 26310247)
1. Investigative Approaches for Oral Delivery of Anticancer Drugs: A Patent Review.
Tariq M; Singh AT; Iqbal Z; Ahmad FJ; Talegaonkar S
Recent Pat Drug Deliv Formul; 2016; 10(1):24-43. PubMed ID: 26310247
[TBL] [Abstract][Full Text] [Related]
2. Advances in oral delivery of anti-cancer prodrugs.
Jain AK; Jain S
Expert Opin Drug Deliv; 2016 Dec; 13(12):1759-1775. PubMed ID: 27292717
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles as delivery carriers for anticancer prodrugs.
Fang JY; Al-Suwayeh SA
Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
[TBL] [Abstract][Full Text] [Related]
4. Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy.
Luo C; Sun J; Du Y; He Z
J Control Release; 2014 Feb; 176():94-103. PubMed ID: 24389337
[TBL] [Abstract][Full Text] [Related]
5. Oral Delivery of Anticancer Agents Using Nanoparticulate Drug Delivery System.
Mathur P; Rawal S; Patel B; Patel MM
Curr Drug Metab; 2019; 20(14):1132-1140. PubMed ID: 31589119
[TBL] [Abstract][Full Text] [Related]
6. Liposome-based drug delivery of various anticancer agents of synthetic and natural product origin: a patent overview.
Akhtar N; Mohammed SA; Singh V; Abdellatif AA; Mohammad HA; Ahad A; Yusuf M; Khadri H; Naz M; Khan O; Rashid M; Khan RA
Pharm Pat Anal; 2020 May; 9(3):87-116. PubMed ID: 32609057
[TBL] [Abstract][Full Text] [Related]
7. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
8. Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics.
Ahmad J; Amin S; Rahman M; Rub RA; Singhal M; Ahmad MZ; Rahman Z; Addo RT; Ahmad FJ; Mushtaq G; Kamal MA; Akhter S
Curr Drug Metab; 2015; 16(8):633-44. PubMed ID: 26264206
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of anticancer drugs III: formulation using drug delivery systems.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):99-104. PubMed ID: 22981667
[TBL] [Abstract][Full Text] [Related]
10. Recent patents survey on self emulsifying drug delivery system.
Jethara SI; Patel AD; Patel MR
Recent Pat Drug Deliv Formul; 2014; 8(3):233-43. PubMed ID: 25146965
[TBL] [Abstract][Full Text] [Related]
11. Targeting P-glycoprotein for effective oral anti-cancer chemotherapeutics.
Bebawy M; Sze DM
Curr Cancer Drug Targets; 2008 Feb; 8(1):47-52. PubMed ID: 18288943
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions.
Gala UH; Miller DA; Williams RO
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188319. PubMed ID: 31678141
[TBL] [Abstract][Full Text] [Related]
13. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of anticancer drugs II: the prodrug strategy.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery of oral anti-cancer fluoropyrimidine agents.
Miura K; Shima H; Takebe N; Rhie J; Satoh K; Kakugawa Y; Satoh M; Kinouchi M; Yamamoto K; Hasegawa Y; Kawai M; Kanazawa K; Fujiya T; Unno M; Katakura R
Expert Opin Drug Deliv; 2017 Dec; 14(12):1355-1366. PubMed ID: 28379040
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of anticancer drugs: challenges and opportunities.
Thanki K; Gangwal RP; Sangamwar AT; Jain S
J Control Release; 2013 Aug; 170(1):15-40. PubMed ID: 23648832
[TBL] [Abstract][Full Text] [Related]
17. Principles of transmucosal delivery of therapeutic agents.
Blanchette J; Kavimandan N; Peppas NA
Biomed Pharmacother; 2004 Apr; 58(3):142-51. PubMed ID: 15082336
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of peptide drugs: barriers and developments.
Hamman JH; Enslin GM; Kotzé AF
BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of anticancer drugs I: general considerations.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):25-34. PubMed ID: 22951365
[TBL] [Abstract][Full Text] [Related]
20. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
Najjar A; Rajabi N; Karaman R
Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
